Skip to main content
Erschienen in: Journal of Gastroenterology 7/2016

04.11.2015 | Original Article—Alimentary Tract

Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population

verfasst von: Dirk W. Schölvinck, Osamu Goto, Cornelis A. Seldenrijk, Raf Bisschops, Joichiro Horii, Yasutoshi Ochiai, Erik J. Schoon, Boudewijn E. Schenk, Toshio Uraoka, Martijn G. H. van Oijen, Jacques J. G. H. M. Bergman, Naohisa Yahagi, Bas L. A. M. Weusten

Erschienen in: Journal of Gastroenterology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

In Japan, palisade vessels (PV) are used to distinguish the esophagogastric junction (EGJ). Elsewhere, the EGJ is defined by the upper end of the gastric folds (GF) and PV are considered difficult to detect. This study evaluated the detection rate of PV in Western patients with Barrett’s esophagus (BE) using white light imaging (WLI) and narrow band imaging (NBI), and quantified any discordance between Western and Japanese criteria for the EGJ.

Methods

In 25 BE patients, the presence and location of PV and GF were determined and biopsies were obtained. High-quality images of the EGJ were collected under different conditions (insufflations–desufflation, WLI–NBI, forward-retroflex approach), resulting in eight different images per patient. The presence of PV on each still image was assessed by a panel of six Western and Japanese endoscopists with expertise in BE.

Results

PV were observed in ≥ 1 images by a majority of the panel (≥ 4 raters) in 100 % of patients during insufflation versus 60 % during desufflation (p < 0.001). WLI and NBI detected PV in 100 and 92 %, respectively (p = 0.50). Interobserver agreement of the panel was ‘moderate’ (κ = 0.51). During endoscopy PV were located a median of 1 cm distal of the GF in 15 patients (63 %), with intestinal metaplasia (IM) in this discordant zone, in 27 % of patients.

Conclusions

PV are visible in most Western BE patients and are best inspected during insufflation. The location of the GF and PV differed in a substantial group of patients, partially with IM in this discordant zone.
Literatur
2.
Zurück zum Zitat American Gastroenterological A, Spechler SJ, Sharma P, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.CrossRef American Gastroenterological A, Spechler SJ, Sharma P, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.CrossRef
3.
Zurück zum Zitat Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.CrossRefPubMed Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.CrossRefPubMed
4.
Zurück zum Zitat Fan X, Snyder N. Prevalence of Barrett’s esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci. 2009;54(3):572–7.CrossRefPubMed Fan X, Snyder N. Prevalence of Barrett’s esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci. 2009;54(3):572–7.CrossRefPubMed
5.
Zurück zum Zitat Hayeck TJ, Kong CY, Spechler SJ, et al. The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23(6):451–7.CrossRefPubMedPubMedCentral Hayeck TJ, Kong CY, Spechler SJ, et al. The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23(6):451–7.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat van Soest EM, Dieleman JP, Siersema PD, et al. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54(8):1062–6.CrossRefPubMedPubMedCentral van Soest EM, Dieleman JP, Siersema PD, et al. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54(8):1062–6.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fujiwara Y, Higuchi K, Shiba M, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett’s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol. 2003;38(6):533–9.PubMed Fujiwara Y, Higuchi K, Shiba M, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett’s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol. 2003;38(6):533–9.PubMed
8.
Zurück zum Zitat Amano Y, Kushiyama Y, Yuki T, et al. Prevalence of and risk factors for Barrett’s esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol. 2006;41(8):873–9.CrossRefPubMed Amano Y, Kushiyama Y, Yuki T, et al. Prevalence of and risk factors for Barrett’s esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol. 2006;41(8):873–9.CrossRefPubMed
9.
Zurück zum Zitat Okita K, Amano Y, Takahashi Y, et al. Barrett’s esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol. 2008;43(12):928–34.CrossRefPubMed Okita K, Amano Y, Takahashi Y, et al. Barrett’s esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol. 2008;43(12):928–34.CrossRefPubMed
10.
Zurück zum Zitat Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study. Gut. 2008;57(10):1354–9.CrossRefPubMed Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study. Gut. 2008;57(10):1354–9.CrossRefPubMed
11.
Zurück zum Zitat Pohl H, Arash H, Ell C, et al. Length of Barrett’s esophagus and cancer risk—implications from a population based study. Gastroenterology. 2014;146(5):S-122.CrossRef Pohl H, Arash H, Ell C, et al. Length of Barrett’s esophagus and cancer risk—implications from a population based study. Gastroenterology. 2014;146(5):S-122.CrossRef
12.
Zurück zum Zitat Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of Barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11(11):1430–6.CrossRefPubMed Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of Barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11(11):1430–6.CrossRefPubMed
13.
Zurück zum Zitat Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–58.CrossRefPubMed Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–58.CrossRefPubMed
14.
Zurück zum Zitat Shibata A, Matsuda T, Ajiki W, et al. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol. 2008;38(7):464–8.CrossRefPubMed Shibata A, Matsuda T, Ajiki W, et al. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol. 2008;38(7):464–8.CrossRefPubMed
15.
Zurück zum Zitat Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.CrossRefPubMed Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.CrossRefPubMed
16.
Zurück zum Zitat Aoki T. Report of research committee on definition of Barrett’s esophagus. Chiba: Japanese Society of Esophageal Diseases; 2000. p. 20–23 (in Japanese). Aoki T. Report of research committee on definition of Barrett’s esophagus. Chiba: Japanese Society of Esophageal Diseases; 2000. p. 20–23 (in Japanese).
17.
Zurück zum Zitat Hamamoto Y, Endo T, Nosho K, et al. Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett’s esophagus. J Gastroenterol. 2004;39(1):14–20.CrossRefPubMed Hamamoto Y, Endo T, Nosho K, et al. Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett’s esophagus. J Gastroenterol. 2004;39(1):14–20.CrossRefPubMed
18.
Zurück zum Zitat Committee ASoP, Evans JA, Early DS, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc.;76(6):1087–94. Committee ASoP, Evans JA, Early DS, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc.;76(6):1087–94.
19.
Zurück zum Zitat Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology. 1993;105(1):40–50.CrossRefPubMed Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology. 1993;105(1):40–50.CrossRefPubMed
20.
Zurück zum Zitat Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol. 2001;36(7):445–56.CrossRefPubMed Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol. 2001;36(7):445–56.CrossRefPubMed
21.
Zurück zum Zitat Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMed
22.
Zurück zum Zitat Hoshihara Y, Kogure T. What are longitudinal vessels? Endoscopic observation and clinical significance of longitudinal vessels in the lower esophagus. Esophagus. 2006;3(4):145–50.CrossRef Hoshihara Y, Kogure T. What are longitudinal vessels? Endoscopic observation and clinical significance of longitudinal vessels in the lower esophagus. Esophagus. 2006;3(4):145–50.CrossRef
23.
Zurück zum Zitat Ogiya K, Kawano T, Ito E, et al. Lower esophageal palisade vessels and the definition of Barrett’s esophagus. Dis Esophagus. 2008;21(7):645–9.CrossRefPubMed Ogiya K, Kawano T, Ito E, et al. Lower esophageal palisade vessels and the definition of Barrett’s esophagus. Dis Esophagus. 2008;21(7):645–9.CrossRefPubMed
24.
Zurück zum Zitat Kumagai Y, Yagi M, Aida J, et al. Detailed features of palisade vessels as a marker of the esophageal mucosa revealed by magnifying endoscopy with narrow band imaging. Dis Esophagus. 2012;25(6):484–90.CrossRefPubMed Kumagai Y, Yagi M, Aida J, et al. Detailed features of palisade vessels as a marker of the esophageal mucosa revealed by magnifying endoscopy with narrow band imaging. Dis Esophagus. 2012;25(6):484–90.CrossRefPubMed
25.
Zurück zum Zitat Kinjo T, Kusano C, Oda I, et al. Prague C&M and Japanese criteria: shades of Barrett’s esophagus endoscopic diagnosis. J Gastroenterol. 2010;45(10):1039–44.CrossRefPubMed Kinjo T, Kusano C, Oda I, et al. Prague C&M and Japanese criteria: shades of Barrett’s esophagus endoscopic diagnosis. J Gastroenterol. 2010;45(10):1039–44.CrossRefPubMed
26.
Zurück zum Zitat Kusano C, Kaltenbach T, Shimazu T, et al. Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction? J Gastroenterol. 2009;44(8):842–6.CrossRefPubMed Kusano C, Kaltenbach T, Shimazu T, et al. Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction? J Gastroenterol. 2009;44(8):842–6.CrossRefPubMed
27.
Zurück zum Zitat Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.CrossRefPubMed Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.CrossRefPubMed
28.
Zurück zum Zitat Whiteman DC, Appleyard M, Bahin FF, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. J Gastroenterol Hepatol. 2015;30(5):804–20.CrossRefPubMed Whiteman DC, Appleyard M, Bahin FF, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. J Gastroenterol Hepatol. 2015;30(5):804–20.CrossRefPubMed
29.
Zurück zum Zitat Melson J, Desai V, Greenspan MM, et al. Negative surveillance endoscopy occurs frequently in patients with short-segment non-dysplastic Barrett’s esophagus. Dis Esophagus. 2015;28(7):660–5.CrossRefPubMed Melson J, Desai V, Greenspan MM, et al. Negative surveillance endoscopy occurs frequently in patients with short-segment non-dysplastic Barrett’s esophagus. Dis Esophagus. 2015;28(7):660–5.CrossRefPubMed
30.
Zurück zum Zitat Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61(7):970–6.CrossRefPubMed Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61(7):970–6.CrossRefPubMed
31.
Zurück zum Zitat Thomas T, Abrams KR, De Caestecker JS, et al. Meta analysis: cancer risk in Barrett’s oesophagus. Aliment Pharmacol Ther. 2007;26(11–12):1465–77.CrossRefPubMed Thomas T, Abrams KR, De Caestecker JS, et al. Meta analysis: cancer risk in Barrett’s oesophagus. Aliment Pharmacol Ther. 2007;26(11–12):1465–77.CrossRefPubMed
32.
Zurück zum Zitat Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 1998;114(4):633–9.CrossRefPubMed Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 1998;114(4):633–9.CrossRefPubMed
33.
Zurück zum Zitat Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol. 1997;92(3):414–8.PubMed Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol. 1997;92(3):414–8.PubMed
34.
Zurück zum Zitat Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43(6):543–9.CrossRefPubMed Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43(6):543–9.CrossRefPubMed
Metadaten
Titel
Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population
verfasst von
Dirk W. Schölvinck
Osamu Goto
Cornelis A. Seldenrijk
Raf Bisschops
Joichiro Horii
Yasutoshi Ochiai
Erik J. Schoon
Boudewijn E. Schenk
Toshio Uraoka
Martijn G. H. van Oijen
Jacques J. G. H. M. Bergman
Naohisa Yahagi
Bas L. A. M. Weusten
Publikationsdatum
04.11.2015
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 7/2016
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-015-1136-2

Weitere Artikel der Ausgabe 7/2016

Journal of Gastroenterology 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.